Impact of primary tumour location on efficacy of bevacizumab plus chemotherapy in metastatic colorectal cancer

BACKGROUND: Two first-line (1L) bevacizumab trials showed the prognostic value of primary tumour location in metastatic colorectal cancer (mCRC). In this retrospective subgroup analysis, further analysis of the predictive effect of bevacizumab is presented. METHODS: Patients with sidedness informati...

Descripción completa

Detalles Bibliográficos
Autores principales: Loupakis, Fotios, Hurwitz, Herbert I., Saltz, Leonard, Arnold, Dirk, Grothey, Axel, Nguyen, Quynh Lan, Osborne, Stuart, Talbot, Jonathan, Srock, Stefanie, Lenz, Heinz-Josef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288128/
https://www.ncbi.nlm.nih.gov/pubmed/30487637
http://dx.doi.org/10.1038/s41416-018-0304-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288128/
https://www.ncbi.nlm.nih.gov/pubmed/30487637
http://dx.doi.org/10.1038/s41416-018-0304-6

Ejemplares similares